林业发展局警告Depo-Provera可能会增加脑肿瘤的风险,敦促长期使用者咨询医生。 FDA warns Depo-Provera may increase brain tumor risk, urging long-term users to consult doctors.

根据新发现的证据, FDA 更新了 Depo-Provera 药物标签, The FDA has updated the label for Depo-Provera, a widely used birth control injection, to warn of a potential link to meningiomas, a type of brain tumor, based on emerging evidence. 这种改变适用于两种药物,继辉瑞在初次拒绝后重新提交之后。 The change applies to two versions of the drug and follows Pfizer’s resubmission after an initial rejection. 尽管先前否认,但现在已经发出警告,警告建议监测长期用户,特别是一年以上使用或31岁后开始使用的人。 The warning, now in place despite prior denials, advises monitoring long-term users, particularly those using it over a year or starting after age 31. 1 000多起诉讼指控Pfizer没有警告病人,尽管该公司认为该药物安全有效。 Over 1,000 lawsuits allege Pfizer failed to warn patients, though the company maintains the drug is safe and effective. 加拿大、欧洲和南非已经存在类似的警告。 Similar warnings already exist in Canada, Europe, and South Africa. 卫生专家敦促用户与其提供方讨论风险和替代办法。 Health experts urge users to discuss risks and alternatives with their provider.